This is a preview of subscription content, log in via an institution to check access.
Reference
NICE. Innovative treatment for gynaecological cancers approved for Cancer Drugs Fund. Internet Document : 26 Jul 2019. Available from: URL: https://www.nice.org.uk/news/article/innovative-treatment-for-gynaecological-cancers-approved-for-cancer-drugs-fund
Rights and permissions
About this article
Cite this article
Olaparib for first-line maintenance in advanced ovarian cancer. PharmacoEcon Outcomes News 834, 37 (2019). https://doi.org/10.1007/s40274-019-6137-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6137-6